1. From the Cardiovascular Division (S.D.S., N.A., H.S., M.A.P.), Department of Medicine, Brigham and Women’s Hospital, Boston, Mass; University of Glasgow (J.J.V.M.), Glasgow, United Kingdom; Sahlgrenska University Hospital/Östra (K.S.), Göteborg, Sweden; Hamilton Health Sciences and McMaster University (S.Y.), Hamilton, Ontario, Canada; Duke University Medical Center (C.B.G.), Durham, NC; AstraZeneca LP (E.L.M.), Wilmington, Del; and London School of Hygiene (D.W., S.P.), London, United Kingdom.